Retinoids inhibit human epidermal keratinocyte RNase P activity

Biological Chemistry

Volumn 384, Issue 3, 2003, Pages 457-462

  Papadimou, Evangelia ^a,c   Pavlidou, Despina ^a   Séraphin, Bertrand ^b   Tsambaos, Dionysios ^a   Drainas, Denis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b CNRS   (France)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

Arotinoids; Retinoids; RNase P; Vitamin A

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID ETHYL ESTER; AROTINOID; ETAROTENE; ETRETIN; RETINOIC ACID; RETINOID DERIVATIVE; RIBONUCLEASE P; TEMAROTENE; TRANSFER RNA;

BIOGENESIS; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; KERATINOCYTE; MOLECULAR MECHANICS; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINOCYTES; KINETICS; RETINOIDS; RIBONUCLEASE P;

EID: 0037729066     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.051     Document Type: Review

References (28)

1. Botling, J., Castro, D. S., Oberg, F., Nilsson, K., and Perlmann, T. (1997). Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation. J. Biol. Chem. 272, 9443-9449.
2. Chamberlain, J., R., Lee, Y., Lane, W. S., and Engelke, D. (1998). Purification and characterization of the nuclear RNase P holoenzyme complex reveals extensive subunit overlap with RNase MRP. Genes Dev. 12, 1678-1690.
3. DeLuca, L. M. (1991). Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5, 2924-2933.
4. Chao, W. R., Hobbs, P. D., Jong, L., Zhang, X. K., Zheng, Y., Wu, Q., Shroot, B., and Dawson, M. I. (1997). Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture. Cancer Lett. 115, 1-7.
5. Doersen, C-J., Guerrier-Takada, C., Altman, S., and Attardi, G. (1985). Characterization of an RNase P activity from HeLa cell mitochondria. J. Biol. Chem. 260, 5942-5949.
6. Drainas, D., Zimmerly, S., Willis, I., and Soll, D. (1989). Substrate structural requirements of Schizosaccharomyces pombe RNase P. FEBS Lett. 251, 84-88.
7. Drainas, D., Papadimou, E., Monastirli, A., Tsambaos, D., and Merk, H. F. (2000). Dose-dependent inhibition of ribonuclease P activity by anthralin. Skin Pharmacol. Appl. Skin Physiol. 13, 128-132.
8. Eder, P. S., Kekuda, R., Stolc, V., and Altman, S. (1997). Characterization of two scleroderma autoimmune antigens that co-purify with human ribonuclease P. Proc. Natl. Acad. Sci. USA 94, 1101-1106.
9. Frank, D. N., and Pace, N. R. (1998). Unity and diversity in a tRNA processing enzyme. Annu. Rev. Biochem. 67, 153-180.
10. Hsu, C. A., Rishi, A. K., Su-Li, X., Gerald, T. M., Dawson, M. I., Schiffer, C., Reichert, U., Shroot, B., Poirer, G. C., and Fontana, J. A. (1997). Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89, 4470-4479.
11. Lacour, M., Mehta-Nikhar, B., Atherton, D. J., and Harper, J. I. (1996). An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br. J. Dermatol. 134, 1023-1029.
12. Leid, M., Kastner, P., and Chambon, P. (1992). Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem. Sci. 17, 427-433.
13. Lippman, S. M., Heyman, R. A., Kurie, J. M., Benner, S. E., and Hong, W. K. (1995). Retinoids and chemoprevention: clinical and basic studies. J. Cell Biochem. (Suppl.) 22, 1-10.
14. Lygerou, Z., Pluk, H., van Venrooij, W. J., and Seraphin, B. (1996). hPop1: an autoantigenic protein subunit shared by the human RNase P and RNase MRP ribonucleoproteins. EMBO J. 15, 5936-5948.
15. Muindi, J. R. (1996). Retinoids in clinical cancer therapy. Cancer Treat. Res. 870, 305-342.
16. Papadimou, E., Georgiou, S., Tsambaos, D., and Drainas, D. (1998). Inhibition of ribonuclease P activity by retinoids. J. Biol. Chem. 273, 24375-24378.
17. Papadimou, E., Monastirli, A., Tsambaos, D., Merk, H. F., and Drainas, D. (2000a). Inhibitory effects of arotinoids on tRNA biogenesis. Skin Pharmacol. Appl. Skin Physiol. 13, 345-51.
18. Papadimou, E., Monastirli, A., Stathopoulos, C., Tsambaos, D., and Drainas, D. (2000b). Modulation of ribonuclease P activity by calcipotriol. Eur. J. Biochem. 267, 1173-1177.
19. Papadimou. E., Monastirli, A., Tsambaos, D., and Drainas, D. (2000c). Additive inhibitory effect of calcipotriol and anthralin on ribonuclease P activity. Biochem. Pharmacol. 60, 91-94.
20. Plewig, G., Albrecht, G., Henz, B. M., Meigel. W., Schopf, E., and Stadler, R. (1997). Systemic treatment of acne with isotretinoin: current status. Hautarzt 48, 881-885.
21. Sankaranarayanan, R., and Mathew, B. (1996). Retinoids as cancer preventive agents. IARC Sci. Publ. 139, 47-59.
22. Segel, I. H. (1993). Enzyme Kinetics (New York, USA: John Wiley & Sons, Inc.), p. 109.
23. Stathopoulos, C., Kalpaxis, D. L., and Drainas, D. (1995). Partial purification and characterization of RNase P from Dictyostelium discoideum. Eur. J. Biochem. 228, 976-980.
24. Stathopoulos, C., Tekos, A., Zarkadis, I. K., and Drainas, D. (2001). Extensive deproteinization of Dictyostelium discoideum RNase P reveals a new catalytic activity. Eur. J. Biochem. 268, 2134-2140.
25. van der Saag, P. T. (1996). Nuclear retinoid receptors: mediators of retinoid effects. Eur. J. Clin. Nutr. 50, (Suppl. 3), 24-28.
26. Wieder, J. M., and Lowe, N. J. (1995). Systemic retinoids for psoriasis. Dermatol. Clin. 13, 891-896.
27. Xiao, S., Scott, F., Fierke, C. A., and Engelke, D. R. (2002). Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes. Annu. Rev. Biochem. 71, 165-189.
28. Zhao, X., Demary, K., Wong, L., Vaziri, C., McKenzie, A. B., Eberlein, T. J., and Spanjaard, R. A. (2001). Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN). Cell Death Differ. 8, 878-886.